Search for: "Cephalon Inc." Results 41 - 60 of 176
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2018, 11:33 am by taotiadmin
The Department of Justice recently announced that Cephalon, Inc., a biopharmaceutical company, will pay $425 million to settle “off-label marketing”… The post $425 Million Settlement In “Off-Label Marketing” Case appeared first on TZ Legal - Fraud Fighters. [read post]
7 Jun 2008, 3:34 am
Included on our list were Cephalon, Inc., which spent $512,000, Abbott Laboratories, which spent $880,000, and Amgen Inc., which spent $2.5 million. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
16 Nov 2008, 9:29 pm
The Federal Drug Administration (FDA) is now warning doctors about severe skin reactions in alcoholism patients who use Vivitrol, an injectable treatment made and marked by Cephalon, Inc. [read post]
13 Aug 2008, 6:46 pm
The FDA is warning doctors about severe skin reactions in alcoholism patients who use Vivitrol, an injectable treatment made and marketed by Cephalon Inc. [read post]
28 May 2015, 1:44 pm by Law360
The Federal Trade Commission's $1.2 billion settlement with Cephalon Inc. over the company's huge payments to rivals is a fresh sign that so-called pay-for-delay deals involving big exchanges of money will be difficult to defend in the wake of a landmark U.S. [read post]
6 Oct 2008, 3:54 pm
In a serious case of products liability, drug maker Cephalon, Inc. will pay $425 million in a settlement for illegally marketing a highly addictive lollipop painkiller and two other pharmaceuticals for non-approved uses. [read post]
2 Oct 2008, 10:18 pm
Drug maker Cephalon Inc. will pay $431 million to settle a number of whistleblower lawsuits accusing the company of promoting drugs for unapproved uses. [read post]
20 Sep 2007, 3:04 pm
This medication, made by the drug company Cephalon, Inc., is prescribed to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea / hypopnea syndrome (OSAHS), and shift work sleep disorder. [read post]
10 Aug 2006, 2:59 pm
The Food and Drug Administration recently rejected approval of Cephalon Inc.'s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]
28 Aug 2017, 10:11 pm by Barry Barnett
Cephalon, Inc., No. 06-c-1797, ECF 1072 (E.D. [read post]